Ataluren
PTC Therapeutics
[]
 approximately 10% 15% of patients with #dmd have a nonsense mutation... ataluren promotes readthrough of the in-frame premature stop codon, enabling the production of full-length dystrophin. jeffrey statland, md, of . #aanam 
Associate editorial director, @Neurology_Live 🧠 and @CGT_Live 🧬 Host of the #MindMoments podcast 🎧 and @medicalwrldnews Deep Dive 📺